dpp-4 inhibitors vs. glp-1 agonist Frontiers | for treating T2DM Frontiers | Clinical Use of

You may experience different side effects with Welchol depending on whether you have high cholesterol, type 2 diabetes, or both

Rhinacanthin C (RC), a representative quinone metabolite characterized by its distinctive conjugated double-bond structure, has achieved three groundbreaking advancements in the treatment of NAFLD: (1) Dual Regulatory Switch: RC establishes a energy sensing-epigenetic regulation dual switch mechanism through allosteric activation of the AMPK subunit (Thr172 phosphorylation 2.8-fold) and enhancement of SIRT1 activity ( 1.9-fold)

MC3R links nutritional state to childhood growth and the timing of puberty

Transformable peptide nanoparticles inhibit the migration of N-cadherin overexpressed cancer cells

Unlike TRT, which completely shuts down natural LH production, HCG monotherapy only partially suppresses the axis